135 related articles for article (PubMed ID: 3196873)
1. Detection of leukemic clone maturation in vivo by premature chromosome condensation.
Hittelman WN; Agbor P; Petkovic I; Andersson B; Kantarjian H; Walters R; Koller C; Beran M
Blood; 1988 Dec; 72(6):1950-60. PubMed ID: 3196873
[TBL] [Abstract][Full Text] [Related]
2. Induction of differentiation in human myeloid leukemia cells with cytosine arabinoside.
Beran M; Hittelman WN; Andersson BS; McCredie KB
Leuk Res; 1986; 10(8):1033-9. PubMed ID: 3462437
[TBL] [Abstract][Full Text] [Related]
3. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
4. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
[TBL] [Abstract][Full Text] [Related]
5. Jumping translocations in leukemia.
Najfeld V; Hauschildt B; Scalise A; Gattani A; Patel R; Ambinder EP; Silverman LR
Leukemia; 1995 Apr; 9(4):634-9. PubMed ID: 7723397
[TBL] [Abstract][Full Text] [Related]
6. Studies on CFU-mix of 47 patients with leukemia and myelodysplastic syndrome.
Chen Y; Wang BM; Li CY; Yu DJ
Chin Med J (Engl); 1989 Jun; 102(6):425-30. PubMed ID: 2512062
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case.
Mozziconacci MJ; Caillères S; Maurice C; Vey N; Sainty D; Blaise D; Lafage-Pochitaloff M
Leukemia; 2003 Sep; 17(9):1901-2. PubMed ID: 12970792
[No Abstract] [Full Text] [Related]
8. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
[TBL] [Abstract][Full Text] [Related]
9. Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.
Bumm T; Müller C; Al-Ali HK; Krohn K; Shepherd P; Schmidt E; Leiblein S; Franke C; Hennig E; Friedrich T; Krahl R; Niederwieser D; Deininger MW
Blood; 2003 Mar; 101(5):1941-9. PubMed ID: 12411298
[TBL] [Abstract][Full Text] [Related]
10. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.
Nakase K; Kita K; Kyo T; Katayama N
Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287
[No Abstract] [Full Text] [Related]
11. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
12. Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.
Padua RA; McGlynn A; McGlynn H
Cancer Treat Res; 2001; 108():111-57. PubMed ID: 11702597
[TBL] [Abstract][Full Text] [Related]
13. Premature chromosome condensation in the study of minimal residual disease.
Hittelman WN; Tigaud JD; Estey E; Vadhan-Raj S
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():9-13. PubMed ID: 2202475
[No Abstract] [Full Text] [Related]
14. The cytogenetics of haematological malignancies.
Berger R
Baillieres Clin Haematol; 1992 Oct; 5(4):791-814. PubMed ID: 1308165
[No Abstract] [Full Text] [Related]
15. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea.
Flamm MJ; Murty VV; Rao PH; Nichols GL
Leuk Res; 2002 Apr; 26(4):417-20. PubMed ID: 11839390
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal relationship between a Ph-negative clone with trisomy 8 associated with severe myelodysplasia and a Ph-positive clone following imatinib treatment in a patient with accelerated-phase chronic myelogenous leukemia (CML).
Patchenko P; Klepfish A; Trakhtenbrot L; Rothman R; Rachmilewitz EA
Am J Hematol; 2004 Dec; 77(4):420. PubMed ID: 15558793
[No Abstract] [Full Text] [Related]
19. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.
Clarkson B; Strife A
Leukemia; 1993 Nov; 7(11):1683-721. PubMed ID: 8231240
[TBL] [Abstract][Full Text] [Related]
20. FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells.
Crescenzi B; Chase A; Starza RL; Beacci D; Rosti V; Gallì A; Specchia G; Martelli MF; Vandenberghe P; Cools J; Jones AV; Cross NC; Marynen P; Mecucci C
Leukemia; 2007 Mar; 21(3):397-402. PubMed ID: 17215855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]